Clinical Trials on Respiratory Virus Infection in Belgium

Total 2901 results

Sciensano
Institute of Tropical Medicine, Belgium; Université Libre de Bruxelles; Mensura...

Completed

Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (PICOV)

COVID-19 | Influenza, Human | SARS Virus | Espiratory Tract Infections

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Endothelial Dysfunction in Covid-19 (ENDOCOVID)

Covid19 | Hypoxemic Respiratory Failure

Belgium
University Hospital, Antwerp

Suspended

Microbiome Therapy in Covid-19 Primary Care Support (MiCel)

Corona Virus Infection | SARS-CoV Infection

Belgium
Cliniques universitaires Saint-Luc- Université...
BioMérieux

Completed

Co-infection Management in COVID-19 Critically Ill

COVID-19

Belgium
Erasme University Hospital
Roche Diagnostics; LHUB-ULB

Terminated

Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room

RSV Infection | Influenza Viral Infections

Belgium
Ablynx

Completed

ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers

Healthy | RSV Infection

Belgium
Lieselot Houspie

Unknown

Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting

Influenza-like Illness | Influenzal Acute Respiratory Infection

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Orthomyxoviridae Infections | Pandemic Influenza | Influenza A Virus Infection

Belgium
Universitair Ziekenhuis Brussel

Unknown

Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males (COVIDSPERM)

COVID-19 | Corona Virus Infection | Sars-CoV2 | Semen

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Coronavirus Pediatric Serological Study (CoPSS)

SARS-CoV2 Infection

Belgium
KU Leuven
University Ghent; Vrije Universiteit Brussel; Universiteit Antwerpen; Université...

Terminated

The DAWN Antivirals Trial for Ambulatory COVID-19 Patients (DAWN)

Covid19 | SARS-CoV Infection

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination

SARS-CoV Infection

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach (HYGIEIA)

SARS-CoV-2 Infection | Influenza Viral Infections

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

In-depth Immunological Investigation of COVID-19. (COntAGIouS)

Coronavirus Infections

Belgium
Tilman S.A.
Artialis

Completed

Covid-19, Hospitalized, PatIents, Nasafytol

Coronavirus Infection

Belgium
University of Liege

Recruiting

Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

Coronavirus Infection

Belgium
University Hospital, Ghent

Completed

Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection (Coser)

SARS-CoV Infection | Immune System Disorder

Belgium
Centre Hospitalier Universitaire Saint Pierre
Institute for Medical Immunology (IMI); Laboratoire Hospitalier Universitaire...

Active, not recruiting

Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children (ELIKYA COVID)

Covid-19 | Pregnancy

Belgium
Janssen Research & Development, LLC

Completed

A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections

Respiratory Syncytial Virus

Belgium
Université Catholique de Louvain
University of Liege; Université Libre de Bruxelles

Active, not recruiting

SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonia - Brussels: An Epidemiological Pilot Study (DYNAtracs)

SARS-CoV-2 Infection

Belgium
Maria Goossens
Institute of Tropical Medicine; Erasme University Hospital; Université Libre... and other collaborators

Active, not recruiting

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations (COVICO)

COVID-19 | SARS CoV 2 Infection

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Hasselt University; Jessa Hospital; Ziekenhuis Oost-Limburg

Unknown

Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study (COVITRA)

Covid19 | SARS-CoV Infection | Transplantation Infection

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Italy, Belgium, France, Lithuania
Institute of Tropical Medicine, Belgium
University Hospital, Antwerp

Completed

COVID-19 Immune Repertoire Sequencing (IMSEQ)

SARS-CoV 2 | COVID | Corona Virus Infection | RDT | B Cell

Belgium
UMC Utrecht
University of Oxford; Universiteit Antwerpen

Unknown

RESCEU Study, Defining the Burden of Disease of RSV in Older Adults

Respiratory Syncytial Virus Infections | Bronchiolitis | RSV Infection

Netherlands, Belgium, United Kingdom
University Ghent

Completed

The Bodily Complaints Barometer: The Impact of the Corona Measures and of Contracting a COVID-19 Infection on the Body. (COVID-MSK)

COVID-19

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Study of the Influenza Vaccine in Adults

Influenza | Orthomyxoviridae Infections

Belgium, Germany, Switzerland
Universitair Ziekenhuis Brussel

Unknown

Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards

Respiratory Tract Infections | SARS-CoV Infection | Antibiotic Resistance | Antimicrobial Stewardship

Belgium
University Hospital, Ghent
European Society of Intensive Care Medicine

Completed

ESICM UNITE COVID-19 Project (UNITE-COVID) (UNITE-COVID)

COVID-19 Infection

Belgium
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Sciensano
McGill University; KU Leuven

Completed

Sero-prevalence COVID-19 Among Belgian Children (SeCoBelChild)

Covid19 | SARS-CoV-2 | SARS-CoV Infection

Belgium
Sciensano
KU Leuven; University of Liege; Universiteit Antwerpen

Active, not recruiting

SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19) (SCOPE)

Covid19 | SARS-CoV-2 Infection

Belgium
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Coalition for Epidemic Preparedness... and other collaborators

Completed

A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)

Lassa Virus Infection

Belgium
Cesa Projects International

Unknown

AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections

Genital Human Papilloma Virus Infection

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Czech Republic, Lithuania, Belgium
University Hospital Inselspital, Berne
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Terminated

CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 (CONVINCE)

COVID-19 | SARS-CoV Infection

Belgium, Switzerland, Italy
Universitair Ziekenhuis Brussel

Recruiting

Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis

Human Papilloma Virus

Belgium
Universiteit Antwerpen

Completed

Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples (HPV-VACPLUS)

Human Papilloma Virus Infection

Belgium
GlaxoSmithKline

Completed

Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women

Respiratory Syncytial Virus Infections

Belgium
Ablynx

Withdrawn

Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Belgium, Spain, Australia
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation

Influenza A Virus

Belgium
Universiteit Antwerpen

Completed

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (ABSOP-FollowUp)

Human Papilloma Virus Infection

Belgium
Universiteit Antwerpen
Research Foundation Flanders

Completed

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study) (AB-SOP)

Human Papilloma Virus Infection

Belgium
Cyril Barbezange
Sciensano; Belgian Federal Public Service, Food Chain Safety and Environment; Agentschap Zorg en Gezondheid

Enrolling by invitation

Zoonotic Influenza Surveillance in Belgium (ZOOIS)

Influenza, Human

Belgium
Osivax
Aepodia

Completed

Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects

Influenza

Belgium
GlaxoSmithKline

Completed

Revaccination With Influenza Vaccine GSK1247446A

Influenza | Influenza, Human

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Influenza

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years

Influenza

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

Influenza

Belgium

Clinical Trials on Respiratory Virus Infection in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations